HADHA, central to mitochondrial fatty acid beta-oxidation, plays a significant role in glioma through its impact on energy metabolism, cell proliferation, oxidative stress, immune response, and therapeutic targeting. This evidence concerns the gene HADHA and central nervous system cancer.